NEUMEGA Side Effects

6785940-0 | Hypoxia, Pleural Effusion, Pulmonary Embolism, Pulmonary Oedema, Pulse Absent
on Jun 22, 2010 Male patient from UNITED STATES , 71 years of age, weighting 274.0 lb, was treated with Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, pleural effusion, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema, pulse absent. Neumega dosage: .

6620269-2 | Arrhythmia
Patient was taking Neumega (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?) on Apr 27, 2007 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with prophylaxis, thrombocytopenia and. Neumega dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6620253-9 | Atrial Tachycardia, Cardiac Enzymes Increased, Dermatitis, Palpitations
Adverse event was reported on Oct 30, 2006 by a Female patient taking Neumega (View Usage) (Dosage: 5 Mg) was diagnosed with thrombocytopenia, colorectal cancer (What is colorectal cancer?) and. Location: UNITED STATES , 68 years of age, weighting 143.1 lb, After Neumega was administered, patient had the following side effects: atrial tachycardia, cardiac enzymes increased, dermatitis, palpitations. During the same period patient was treated with LEUCOVORIN CALCIUM (^folfox^ Dose Not Provided) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), OXALIPLATIN (^folfox^ Dose Not Provided) (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (^folfox^ Dose Not Provided) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6620251-5 | Arrhythmia
on Jan 07, 2008 Male patient from UNITED STATES , 68 years of age, was diagnosed with oesophageal carcinoma and was treated with Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?). Neumega dosage: 50 Mg/kg. Patient was hospitalized.


6620250-3 | Ascites, Condition Aggravated, Oedema Peripheral
on Jun 11, 2007 Female patient from UNITED STATES , 52 years of age, weighting 214.2 lb, was diagnosed with thrombocytopenia and was treated with Neumega (View Usage). Patient had the following side effects: ascites, condition aggravated, oedema peripheral. Neumega dosage: . During the same period patient was treated with COMPAZINE (10 Mg As Needed) (View Compazine Review and Compazine Label ), PERCOCET (5 Mg/325 Mg; 1 Or 2 Tabs Every 4 Hrs) (View Percocet Review and Percocet Label ), PROTONIX (View Protonix Review and Protonix Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), DECADRON (4 Mg) (View Decadron Review and Decadron Label ).

6620249-7 | Arrhythmia
Patient was taking Neumega (View Usage). After Neumega was administered, patient had the following side effects: arrhythmia (What is arrhythmia?) on Jan 07, 2008 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with non-small cell lung cancer and. Neumega dosage: 50 Mg/kg For 5 Doses. Patient was hospitalized.

6620138-8 | Bone Pain
Adverse event was reported on Oct 28, 2005 by a Male patient taking Neumega (View Usage) (Dosage: 5 Mg (frequency Not Specified)) was diagnosed with thrombocytopenia, anaemia, neutropenia and. Location: UNITED STATES , 46 years of age, weighting 256.2 lb, Patient experienced the following unwanted or unexpected effects: bone pain. During the same period patient was treated with ARANESP (500 Mcg (frequency Not Specified)) (View Aranesp Review and Aranesp Label ), NEULASTA (5 Mg (frequency Not Specified)) (View Neulasta Review and Neulasta Label ).

6620137-6 | Capillary Leak Syndrome, Pulmonary Oedema
on Apr 07, 2006 Female patient from UNITED STATES , weighting 160.1 lb, was diagnosed with thrombocytopenia, non-hodgkin's lymphoma and was treated with Neumega (View Usage). Patient had the following side effects: capillary leak syndrome, pulmonary oedema. Neumega dosage: 3.6 Mg X3 Days (50 Ug/kg Daily). During the same period patient was treated with VINCRISTINE (Dose Not Provided) (View Vincristine Review and Vincristine Label ), PREDNISONE (Dose Not Provided) (View Prednisone Review and Prednisone Label ), CYCLOPHOSPHAMIDE (Dose Not Provided) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN (Dose Not Provided) (View Doxorubicin Review and Doxorubicin Label ). Patient was hospitalized.

6620135-2 | Atrial Fibrillation
on Feb 27, 2006 Male patient from UNITED STATES , weighting 192.2 lb, was diagnosed with platelet count decreased, thrombocytopenia and was treated with Neumega (View Usage). After Neumega was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Neumega dosage: 50 Ug/kg One Time Per Day. During the same period patient was treated with PREDNISONE (Once A Day (dose Not Provided)) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6620134-0 | Malaise, Nausea
Patient was taking Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, nausea (What is nausea?) on Mar 28, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 165.1 lb, was diagnosed with thrombocytopenia, prophylaxis of nausea and vomiting and. Neumega dosage: 2.5 Mg As Required. During the same period patient was treated with METOPROLOL SUCCINATE (Dose Details Not Provided) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), NEUPOGEN (Dose Details Not Provided) (View Neupogen Review and Neupogen Label ), ZOFRAN (Dose Not Provided/twice Per Day) (View Zofran Review and Zofran Label ), ARANESP (Dose Details Not Provided) (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

6013991-2 | Capillary Leak Syndrome, Oedema Peripheral
Adverse event was reported on Dec 15, 2008 by a Male patient taking Neumega (View Usage) (Dosage: ) was diagnosed with platelet count decreased, neuropathy peripheral and. Location: UNITED STATES , weighting 207.2 lb, Patient had the following side effects: capillary leak syndrome, oedema peripheral. During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ), ELIDEL (View Elidel Review and Elidel Label ), LYRICA (View Lyrica Review and Lyrica Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ), MINOCIN (View Minocin Review and Minocin Label ).

5953148-4 | Arthralgia, Condition Aggravated, Decreased Activity, Fibromyalgia, Oedema Peripheral
on Oct 08, 2008 Female patient from UNITED STATES , 68 years of age, weighting 140.1 lb, was diagnosed with anaemia, myelodysplastic syndrome and was treated with Neumega (View Usage). After Neumega was administered, patient had the following side effects: arthralgia, condition aggravated, decreased activity, fibromyalgia, oedema peripheral. Neumega dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), KLONOPIN (0.5mg Hs) (View Klonopin Review and Klonopin Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), ARANESP (View Aranesp Review and Aranesp Label ), AMITRIPTYLINE HCL (200mg Qhs) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5915602-0 | Arthralgia, Condition Aggravated, Decreased Activity, Fibromyalgia, Oedema Peripheral
on Oct 08, 2008 Female patient from UNITED STATES , 68 years of age, weighting 140.1 lb, was diagnosed with anaemia, myelodysplastic syndrome and was treated with Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, condition aggravated, decreased activity, fibromyalgia, oedema peripheral. Neumega dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), KLONOPIN (0.5mg Hs) (View Klonopin Review and Klonopin Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), ARANESP (View Aranesp Review and Aranesp Label ), AMITRIPTYLINE HCL (200mg Qhs) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5902057-5 | Capillary Leak Syndrome, Oedema Peripheral
Patient was taking Neumega (View Usage). Patient had the following side effects: capillary leak syndrome, oedema peripheral on Sep 19, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 207.2 lb, was diagnosed with platelet count decreased and. Neumega dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), MINOCIN (View Minocin Review and Minocin Label ), ELIDEL (View Elidel Review and Elidel Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ), COMPAZINE (View Compazine Review and Compazine Label ).

5849679-8 | Dizziness, Dysarthria, Dyspnoea, Fatigue, Palpitations
Adverse event was reported on Aug 18, 2008 by a Male patient taking Neumega (View Usage) (Dosage: 5 Mg 1 Sq) was diagnosed with platelet count decreased and. Location: UNITED STATES , 54 years of age, weighting 175.0 lb, After Neumega was administered, patient had the following side effects: dizziness (What is dizziness?), dysarthria, dyspnoea, fatigue, palpitations. Patient was hospitalized.

5847382-1 | Arthralgia, Condition Aggravated, Decreased Activity, Fibromyalgia, Oedema Peripheral
on Aug 06, 2008 Female patient from UNITED STATES , 68 years of age, weighting 140.1 lb, was diagnosed with anaemia, myelodysplastic syndrome and was treated with Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, condition aggravated, decreased activity, fibromyalgia, oedema peripheral. Neumega dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), KLONOPIN (0.5mg Hs) (View Klonopin Review and Klonopin Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), ARANESP (View Aranesp Review and Aranesp Label ), AMITRIPTYLINE HCL (200mg Qhs) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5846956-1 | Arthralgia, Condition Aggravated, Decreased Activity, Fibromyalgia, Oedema Peripheral
on Aug 06, 2008 Female patient from UNITED STATES , 68 years of age, weighting 140.1 lb, was diagnosed with anaemia, myelodysplastic syndrome and was treated with Neumega (View Usage). Patient had the following side effects: arthralgia, condition aggravated, decreased activity, fibromyalgia, oedema peripheral. Neumega dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), KLONOPIN (0.5mg Hs) (View Klonopin Review and Klonopin Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), ARANESP (View Aranesp Review and Aranesp Label ), AMITRIPTYLINE HCL (200mg Qhs) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5505959-7 | Respiratory Depression
Patient was taking Neumega (View Usage). After Neumega was administered, patient had the following side effects: respiratory depression on Oct 31, 2007 from CANADA Additional patient health information: Female patient , weighting 72.97 lb, was diagnosed with thrombocytopenia, nephroblastoma, pain (What is pain?) and. Neumega dosage: . During the same period patient was treated with VINCRISTINE (Every Three Weeks In Cycles) (View Vincristine Review and Vincristine Label ), IRINOTECAN HCL (Every 3 Weeks In Cycles) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ).

5371678-3 | Abdominal Distension, Dyspnoea, Fluid Retention, Injection Site Rash, International Normalised Ratio Increased, Muscle Fatigue, Oedema, Oedema Peripheral
Adverse event was reported on Jun 15, 2007 by a Female patient taking Neumega (View Usage) (Dosage: ) was diagnosed with platelet count decreased, cardiac ablation and. Location: UNITED STATES , weighting 138.1 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, dyspnoea, fluid retention, injection site rash, international normalised ratio increased, muscle fatigue, oedema, oedema peripheral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), NEULASTA (View Neulasta Review and Neulasta Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

5289517-8 | Dyspnoea, Oedema, Weight Increased
on Mar 27, 2007 Male patient from UNITED STATES , 67 years of age, was diagnosed with thrombocytopenia, prophylaxis, acute lymphocytic leukaemia and was treated with Neumega (View Usage). Patient had the following side effects: dyspnoea, oedema, weight increased. Neumega dosage: 30 Mcg/kg Once Daily. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ).

5157191-7 | Atrial Tachycardia, Cardiac Enzymes Increased, Dermatitis, Palpitations
on Oct 30, 2006 Female patient from UNITED STATES , 68 years of age, weighting 143.1 lb, was diagnosed with thrombocytopenia and was treated with Neumega (View Usage). After Neumega was administered, patient had the following side effects: atrial tachycardia, cardiac enzymes increased, dermatitis, palpitations. Neumega dosage: 5 Mg, Subcutaneous. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN (LEUCOVORIN) (View Leucovorin (leucovorin) Review and Leucovorin (leucovorin) Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5092493-4 | Breast Cancer, Cerebrovascular Accident, Neoplasm Progression
Patient was taking Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), cerebrovascular accident, neoplasm progression on Aug 11, 2006 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with platelet count decreased and. Neumega dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ). Patient was hospitalized.

5052835-2 | Cerebrovascular Accident, Cerebrovascular Disorder
Adverse event was reported on Jun 23, 2006 by a Female patient taking Neumega (View Usage) (Dosage: ) was diagnosed with platelet count decreased and. Location: UNITED STATES , 61 years of age, Patient had the following side effects: cerebrovascular accident, cerebrovascular disorder. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ). Patient was hospitalized.

4935030-4 | Atrial Fibrillation, Atrial Flutter, Tachycardia
on Mar 06, 2006 Male patient from UNITED STATES , weighting 136.0 lb, was treated with Neumega (View Usage). After Neumega was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), atrial flutter, tachycardia. Neumega dosage: 3.5 Mg. Patient was hospitalized.

4690823-6 | Alanine Aminotransferase Increased, Angiopathy, Aortic Dilatation, Aspartate Aminotransferase Increased, Atherosclerosis, Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Blood Glucose Increased, Blood Potassium Increased
on May 27, 2005 Female patient from , 80 years of age, weighting 115.1 lb, was diagnosed with thrombocytopenia and was treated with Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, angiopathy, aortic dilatation, aspartate aminotransferase increased, atherosclerosis, blood alkaline phosphatase increased, blood creatinine increased, blood glucose increased, blood potassium increased. Neumega dosage: 5 Mg Each, 2 Doses Were Given, Subcutaneous. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PROTONIX (View Protonix Review and Protonix Label ), PAXIL (View Paxil Review and Paxil Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SEPTRA (View Septra Review and Septra Label ), COMBIVENT (View Combivent Review and Combivent Label ).

4685557-8 | Cardiac Arrest, Dehydration, Feeling Abnormal, Nausea, Platelet Count Decreased
Patient was taking Neumega (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), dehydration, feeling abnormal, nausea (What is nausea?), platelet count decreased on May 17, 2005 from Additional patient health information: Male patient , 77 years of age, weighting 165.1 lb, was diagnosed with thrombocytopenia and. Neumega dosage: 3.8 Mg Daily, Given X2, Subcutaneous. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), THALIDOMIDE (THALIDOMIDE) (View Thalidomide (thalidomide) Review and Thalidomide (thalidomide) Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZOMETA (View Zometa Review and Zometa Label ), REMERON (View Remeron Review and Remeron Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ).

4600776-4 | Atrial Fibrillation, Hypokalaemia, Hypomagnesaemia
Adverse event was reported on Feb 09, 2005 by a Male patient taking Neumega (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: , 52 years of age, After Neumega was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), hypokalaemia, hypomagnesaemia. During the same period patient was treated with PEG INTRON (Subcutaneous) (View Peg-intron Review and Peg-intron Label ), REBETOL (View Rebetol Review and Rebetol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), TYLENOL (View Tylenol Review and Tylenol Label ), AMINO ACIDS (AMINO ACIDS) (View Amino Acids (amino Acids) Review and Amino Acids (amino Acids) Label ). Patient was hospitalized.

4593882-4 | Eye Oedema, Lung Neoplasm Malignant, Malignant Neoplasm Progression, Optic Neuritis
on Feb 07, 2005 Male patient from , 62 years of age, weighting 179.2 lb, was diagnosed with platelet count decreased and was treated with Neumega (View Usage). Patient experienced the following unwanted or unexpected effects: eye oedema, lung neoplasm malignant, malignant neoplasm progression, optic neuritis. Neumega dosage: 4200 Mcg, Subcutaneous. During the same period patient was treated with PROCRIT (ERYTHROPOIETIN) (View Procrit (erythropoietin) Review and Procrit (erythropoietin) Label ), NEULASTA (View Neulasta Review and Neulasta Label ), ZOFRAN (View Zofran Review and Zofran Label ), REGLAN (View Reglan Review and Reglan Label ), DECADRON (View Decadron Review and Decadron Label ), ATIVAN (View Ativan Review and Ativan Label ), BENADRYL (View Benadryl Review and Benadryl Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized and became disabled.